News and Commentary | Published:

Acquisition as a best-case scenario

Bio/Technologyvolume 13pages426427 (1995) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Author information

Affiliations

  1. vice president of research and biotechnology/pharmaceutical analyst at Wedbush Morgan Securities, Los Angeles, CA

    • Fariba Fischel Ghodsian

Authors

  1. Search for Fariba Fischel Ghodsian in:

About this article

Publication history

Issue Date

DOI

https://doi.org/10.1038/nbt0595-426